What Nobody Tells You About Melanotan I Side Effects

Melanotan I at a glance:

• Drug class: Cosmetic peptide
• Route: topical for most; injectable melanotans are unlicensed
• Typical frequency: daily topical application typical
• Half-life: topical residence time varies

Side effects are the single biggest reason people quit Melanotan I during the first eight weeks. Most of them are predictable and most of them improve. Knowing which is which up front makes the difference.

Common Side Effects of Melanotan I

The side effects most often reported with Melanotan I:

• Irritation — monitor and discuss with your clinician if it persists or worsens.
• Contact dermatitis (topical) — monitor and discuss with your clinician if it persists or worsens.
• GI effects, blood pressure changes (injectable melanotans) — monitor and discuss with your clinician if it persists or worsens.

These tend to be dose-related. They are most prominent during dose escalation and typically improve once the body adapts to a steady dose.

Serious Risks

Less common but important:

• Atypical melanocytic lesions and other adverse events have been reported with injectable melanotans — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.

How to Manage Common Side Effects

Track what you feel. Side effects are easier to discuss when you have a record of when they appear and how severe they are.

Don't change the dose on your own. Many side effects improve with time at a steady dose; stopping and restarting often resets the adaptation period.

Stay hydrated and eat regularly. Generic advice that nonetheless prevents many otherwise-avoidable side-effect calls.

Communicate with your clinician. Most side effects have a management strategy; the worst outcomes happen when people stop the drug silently and don't get the next-step plan.

For dose-titration questions, see our Melanotan I dosage guide.

Side Effects vs. Withdrawal Effects

It's worth distinguishing between side effects (from taking the drug) and withdrawal or rebound effects (from stopping it). For Melanotan I, the most relevant rebound concern is compound-specific — see the prescribing information.

When to Stop and Call Someone

These symptoms warrant prompt clinical evaluation:

• Severe abdominal pain (especially radiating to the back) — possible pancreatitis
• Vision changes
• Signs of allergic reaction (hives, throat tightness, difficulty breathing)
• Severe vomiting or dehydration
• Persistent symptoms that worsen rather than improve

Side Effects in Context

Most people who take Melanotan I experience some side effects. Most of those are tolerable and improve with time. The decision to continue is a balance between benefit and tolerance, made together with a clinician.

For people weighing whether Melanotan I is the right fit, our Melanotan I results page covers the upside.

Bottom Line

Most Melanotan I side effects improve with time at a steady dose. The minority that don't usually have a management strategy worth trying before stopping the drug.

Frequently Asked Questions

Related Reading

• What Is Melanotan I? Everything You Should Know Before Starting
• Melanotan I Results: What the Real Numbers Show in 2026
• How Much Does Melanotan I Really Cost? The Honest Breakdown
• Understanding Melanotan I Cycling: What the Research Says
• Melanotan II Explained: How It Works and Who It's For
• Melanotan II Side Effects in 2026: Real Reports, Real Solutions

Sources

• Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. J Biomater Sci Polym Ed 2008;19:969.
• Habbema L et al. Risks of Unregulated Use of Alpha-Melanocyte-Stimulating Hormone Analogues. Br J Dermatol 2017;176:633.

This page is informational only and is not medical advice. Stop Melanotan I and seek medical attention if you experience severe symptoms.